RECURRENT GLIOSARCOMA

Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2

Radioactive antibody and immunotherapy combo targets recurrent brain cancer

Disease control Not yet recruiting

This early-phase trial tests a new combination for recurrent glioblastoma, a fast-growing brain tumor. The treatment pairs Actimab-A, a radioactive antibody that seeks out cancer cells, with cemiplimab, an immunotherapy that helps the immune system attack tumors. About 30 adults …

Matched conditions: RECURRENT GLIOSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

RECURRENT GLIOSARCOMA

Get alerted when new RECURRENT GLIOSARCOMA trials appear

Radioactive antibody and immunotherapy combo targets recurrent brain cancer